Former Heritage Pharma Execs To Cooperate In Generics Probe

court-ruling

In the summer of 2014, the state of Connecticut began an investigation into the price increases of certain generic drugs. The investigation is ongoing, and has since expanded to 40 other states and territories. Heritage Pharmaceuticals is a defendant. Two former Heritage Pharma execs–Jason Malek, former President, and Jeffrey Glazer, former chairman and CEO, will be cooperating with the investigation where spans multiple generic drugs, drug companies, and executives.

Read the source article at HartfordBusiness.com

About the Author

Related Posts

Leave a Reply